Literature DB >> 34905963

Regenerative medicine and traumatic brain injury: from stem cell to cell-free therapeutic strategies.

Lianxu Cui1, Yasmeen Saeed2, Haomin Li1, Jingli Yang3.   

Abstract

Traumatic brain injury (TBI) is a serious health concern, yet there is a lack of standardized treatment to combat its long-lasting effects. The objective of the present study was to provide an overview of the limitation of conventional stem-cell therapy in the treatment of TBI and to discuss the application of novel acellular therapies and their advanced strategies to enhance the efficacy of stem cells derived therapies in the light of published study data. Moreover, we also discussed the factor to optimize the therapeutic efficiency of stem cell-derived acellular therapy by overcoming the challenges for its clinical translation. Hence, we concluded that acellular therapy possesses the potential to bring a breakthrough in the field of regenerative medicine to treat TBI.

Entities:  

Keywords:  acellular therapy; cell secretome; exosomes; paracrine effects; regenerative medicine; traumatic brain injury

Mesh:

Year:  2021        PMID: 34905963     DOI: 10.2217/rme-2021-0069

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  1 in total

1.  Human umbilical cord mesenchymal stem cell-derived exosomes promote neurological function recovery in rat after traumatic brain injury by inhibiting the activation of microglia and astrocyte.

Authors:  Lianxu Cui; Wei Luo; Wenkang Jiang; Haomin Li; Junrong Xu; Xiaocui Liu; Bingyun Wang; Jinhui Wang; Guoqiang Chen
Journal:  Regen Ther       Date:  2022-08-28       Impact factor: 3.651

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.